Total raised
$2.2M
Last: Seed 2015-01
Stage
Acquired
Founded
2013
Headcount
4
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
GeneSort is a molecular diagnostics company focused on integrating molecular genomics with personalized therapeutic approaches. The company's mission is to use patients' genetic DNA profile to assist physicians in selecting safe, effective, tailored treatments. GeneSort is focused on providing diagnostic services in the areas of cancer and hereditary diseases. The company has been acquired in July 2018 by Hong Kong investment fund AID Partners for $23 million.
Funding history · 1 round · $2.2M total
2015-01
Seed
$2.2M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
ConsumersDemographics & FamilyWomenEducation & AcademiaHealthcare & Life SciencesHealthcareInsurance CompaniesProvidersLaboratories
Business model
B2BB2G
Tags
genomicsmedical-technologiesbioinformaticscancerdiagnosticsearly-detectiononcologywomen-healthtargeted-therapylaboratorieshospitalsacademiainsurance-companiespersonalized-medicine